Literature DB >> 22801715

Time-dependent changes in glucose and insulin regulation during intermittent hypoxia and continuous hypoxia.

Euhan J Lee1, Laura C Alonso, Darko Stefanovski, Hilary C Strollo, Lia C Romano, Baobo Zou, Srikanth Singamsetty, Keith A Yester, Kenneth R McGaffin, Adolfo Garcia-Ocana, Christopher P O'Donnell.   

Abstract

Hypoxia manifests in many forms including the short repetitive intermittent hypoxia (IH) of sleep apnoea and the continuous hypoxia (CH) of altitude, both of which may impact metabolic function. Based on our own previous studies and the available literature, we hypothesized that whereas acute exposure to IH and CH would lead to comparable metabolic dysfunction, with longer-term exposure, metabolism would normalize to a greater extent with CH than IH. Studies were conducted in lean C57BL/6J mice exposed to either IH or CH for 1 day or 4 weeks and compared to either intermittent air (IA) or unhandled (UN) controls, respectively. We utilized the frequently sampled intravenous glucose tolerance test and minimal model analyses to determine insulin-dependent (insulin sensitivity; S (I)) and insulin-independent (glucose effectiveness; S (g)) glucose disposal, as well as the insulin response to glucose (acute insulin response to glucose; AIR(g)). Our data show that 1-day exposure impaired the glucose tolerance and caused reductions in S (g) and AIR(g) in both the IH and CH groups, but only IH caused a significant decrease in S (I) (7.5 ± 2.7 vs. 17.0 ± 5.3 μU ml(-1) min(-1); p < 0.05). After 4-week exposure, there was evidence of metabolic adaptation in both hypoxic groups, however, in the CH group, there was a supranormal increase in S (I) relative to both UN and IH groups. We conclude that in lean mice, the marked metabolic dysfunction that occurs with acute exposure to hypoxia is reversed to a greater extent with chronic CH exposure than chronic IH exposure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22801715      PMCID: PMC3590809          DOI: 10.1007/s00421-012-2452-3

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  26 in total

1.  Fetal cardiac natriuretic peptide expression and cardiovascular hemodynamics in endotoxin-induced acute cardiac dysfunction in mouse.

Authors:  Kaarin Mäkikallio; Samuli Rounioja; Olli Vuolteenaho; Jenna Paakkari; Mikko Hallman; Juha Räsänen
Journal:  Pediatr Res       Date:  2006-02       Impact factor: 3.756

2.  Intermittent hypoxia causes insulin resistance in lean mice independent of autonomic activity.

Authors:  Nao Iiyori; Laura C Alonso; Jianguo Li; Mark H Sanders; Adolfo Garcia-Ocana; Robert M O'Doherty; Vsevolod Y Polotsky; Christopher P O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2007-02-01       Impact factor: 21.405

3.  Higher blood flow and circulating NO products offset high-altitude hypoxia among Tibetans.

Authors:  S C Erzurum; S Ghosh; A J Janocha; W Xu; S Bauer; N S Bryan; J Tejero; C Hemann; R Hille; D J Stuehr; M Feelisch; C M Beall
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-30       Impact factor: 11.205

4.  Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes.

Authors:  Sophie D West; Debby J Nicoll; Tara M Wallace; David R Matthews; John R Stradling
Journal:  Thorax       Date:  2007-06-08       Impact factor: 9.139

5.  Acute and chronic cardiovascular effects of intermittent hypoxia in C57BL/6J mice.

Authors:  M J Campen; L A Shimoda; C P O'Donnell
Journal:  J Appl Physiol (1985)       Date:  2005-07-07

6.  Glucose infusion in mice: a new model to induce beta-cell replication.

Authors:  Laura C Alonso; Takuya Yokoe; Pili Zhang; Donald K Scott; Seung K Kim; Christopher P O'Donnell; Adolfo Garcia-Ocaña
Journal:  Diabetes       Date:  2007-03-30       Impact factor: 9.461

7.  Obstructive sleep apnea is independently associated with insulin resistance.

Authors:  Mary S M Ip; Bing Lam; Matthew M T Ng; Wah Kit Lam; Kenneth W T Tsang; Karen S L Lam
Journal:  Am J Respir Crit Care Med       Date:  2002-03-01       Impact factor: 21.405

8.  Intermittent hypoxia reverses the diurnal glucose rhythm and causes pancreatic beta-cell replication in mice.

Authors:  Takuya Yokoe; Laura C Alonso; Lia C Romano; Taylor C Rosa; Robert M O'Doherty; Adolfo Garcia-Ocana; Kenji Minoguchi; Christopher P O'Donnell
Journal:  J Physiol       Date:  2007-11-22       Impact factor: 5.182

9.  Endothelial nitric oxide synthase stimulates aneurysm growth in aged mice.

Authors:  Jose M Pimiento; Stephen P Maloney; Paul C Y Tang; Akihito Muto; Tormod S Westvik; Tamara N Fitzgerald; Tiffany T Fancher; George Tellides; Alan Dardik
Journal:  J Vasc Res       Date:  2008-01-10       Impact factor: 1.934

10.  Residents at high altitude show a lower glucose profile than sea-level residents throughout 12-hour blood continuous monitoring.

Authors:  Oscar Castillo; Orison O Woolcott; Elizabeth Gonzales; Victoria Tello; Lida Tello; Carmen Villarreal; Nicolás Méndez; Lucy Damas; Edgar Florentini
Journal:  High Alt Med Biol       Date:  2007       Impact factor: 1.981

View more
  26 in total

Review 1.  Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea.

Authors:  Luciano F Drager; Vsevolod Y Polotsky; Christopher P O'Donnell; Sergio L Cravo; Geraldo Lorenzi-Filho; Benedito H Machado
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-31       Impact factor: 4.733

2.  Intermittent hypoxia maintains glycemia in streptozotocin-induced diabetic rats.

Authors:  Xiaofei Chen; Tong Zhao; Xin Huang; Liying Wu; Kuiwu Wu; Ming Fan; Lingling Zhu
Journal:  Cell Stress Chaperones       Date:  2016-02-22       Impact factor: 3.667

Review 3.  Intermittent hypoxemia and OSA: implications for comorbidities.

Authors:  Naresh A Dewan; F Javier Nieto; Virend K Somers
Journal:  Chest       Date:  2015-01       Impact factor: 9.410

4.  Intermittent hypoxia-induced glucose intolerance is abolished by α-adrenergic blockade or adrenal medullectomy.

Authors:  Jonathan C Jun; Mi-Kyung Shin; Ronald Devera; Qiaoling Yao; Omar Mesarwi; Shannon Bevans-Fonti; Vsevolod Y Polotsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-14       Impact factor: 4.310

5.  Resveratrol attenuates intermittent hypoxia-induced macrophage migration to visceral white adipose tissue and insulin resistance in male mice.

Authors:  Alba Carreras; Shelley X L Zhang; Isaac Almendros; Yang Wang; Eduard Peris; Zhuanhong Qiao; David Gozal
Journal:  Endocrinology       Date:  2014-11-18       Impact factor: 4.736

Review 6.  Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea.

Authors:  Brian D Kent; Walter T McNicholas; Silke Ryan
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

7.  Effects of intermittent hypoxia training on leukocyte pyruvate dehydrogenase kinase 1 (PDK-1) mRNA expression and blood insulin level in prediabetes patients.

Authors:  Tetiana V Serebrovska; Alla G Portnychenko; Vladimir I Portnichenko; Lei Xi; Egor Egorov; Ivanna Antoniuk-Shcheglova; Svitlana Naskalova; Valeriy B Shatylo
Journal:  Eur J Appl Physiol       Date:  2019-01-30       Impact factor: 3.078

8.  Quantitative and temporal control of oxygen microenvironment at the single islet level.

Authors:  Joe Fu-Jiou Lo; Yong Wang; Zidong Li; Zhengtuo Zhao; Di Hu; David T Eddington; Jose Oberholzer
Journal:  J Vis Exp       Date:  2013-11-17       Impact factor: 1.355

9.  Inhibition of Lipolysis Ameliorates Diabetic Phenotype in a Mouse Model of Obstructive Sleep Apnea.

Authors:  Martin Weiszenstein; Larissa A Shimoda; Michal Koc; Ondrej Seda; Jan Polak
Journal:  Am J Respir Cell Mol Biol       Date:  2016-08       Impact factor: 6.914

10.  The effect of adrenal medullectomy on metabolic responses to chronic intermittent hypoxia.

Authors:  Mi-Kyung Shin; Woobum Han; Shannon Bevans-Fonti; Jonathan C Jun; Naresh M Punjabi; Vsevolod Y Polotsky
Journal:  Respir Physiol Neurobiol       Date:  2014-08-29       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.